Satisfaction with life in a group of psoriasis patients

Postepy Dermatologii i Alergologii

Volumn 30, Issue 2, 2013, Pages 85-90

  Jankowiak, Barbara ^a,b   Sekmistrz, Sylwia ^b   Kowalewska, Beata ^a,b   Niczyporuk, Wiaczesław ^b   Krajewska Kułak, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b State College of Computer Science and Business Administration   (Poland)

Author keywords

Psoriasis; Quality of life; Satisfaction with life

Indexed keywords

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; DEPRESSION; DISEASE SEVERITY; ERYTHRODERMIC PSORIASIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; PATIENT SATISFACTION; POLAND; PSORIASIS VULGARIS; QUALITY OF LIFE; SELF EVALUATION; SHAME;

EID: 84878447426     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: 10.5114/pdia.2013.34156     Document Type: Article

References (33)

1. Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005, 64: ii18- ii23.
2. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-71.
3. Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137: 280-4.
4. Zejda JE, Brozek GM, Farnik M, Smółka I. Social and familyrelated correlates of medical care utilization by asthmatic children in Upper Silesia, Poland. Ann Agric Environ Med 2012; 19: 141-5.
5. Rasmy H, Mikhael N, Ismail S. Interleukin-18 expression and the response to treatment in patients with psoriasis. Arch Med Sci 2011; 7: 713-9.
6. Finkelstein J, Lapshin O, Wasserman E. Randomized study of different anti-stigma media. Patient Educ Couns 2008; 71: 204-14.
7. Gelfand J, Feldman S, Stern R, et al. Determinants of quality of life patients with psoriasis: a study from the U.S. population. J Am Acad Dermatol 2004; 51: 704-8.
8. Evers AW, Lu Y, Duller P, et al. Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis. Br J Dermatol 2005; 152: 1275-81.
9. Diener E, Emmons RA, Larson RJ, et al. The satisfaction with life scale. J Pers Assess 1985; 49: 71-8.
10. Juczynski Z. Measurement tools, promotion and health psychology. Pracownia Testów Psychologicznych PTP, Warsaw 2009; 128-36.
11. Zawadzki B, Popiel A, Praglowsck E. Psychometric properties of the Polish version of the Aaron T. Beck's Depression Inventory BDI-II [Polish]. Psychologia Etologia Genetyka 2009; 19: 71-95.
12. Christophers E. Psoriasis - epidemiology and clinical spectrum. Clin Exp Dermatol 2001; 26: 314-20.
13. Elder JT, Nair RP, Voorhees JJ. Epidemiology and the genesis of psoriasis. J Invest Dermatol 1994; 102: 24S-7S.
14. Naldi L. Psoriasis. Dermatol Clin 1995; 13: 635-47.
15. Chren MM, Lasek RJ, Quinn LM, et al. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol 1997; 108: 103-7.
16. De Korte J, Mombers FM, Sprangers MA, et al. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol 2002; 138: 1221-7.
17. Koo J. Population - based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996; 14: 485-96.
18. Weiss SC, Kimball AB, Liewehr DJ, et al. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 2002; 47: 512-8.
19. Zachariae R, Zachariae C, Ibsen H, et al. Dermatology life quality index: data from Danish inpatients and outpatients. Acta Derm Venereol 2000; 80: 272-6.
20. Kimball AB, Jacobson C, Weiss S, et al. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005; 6: 383-92.
21. Jankowiak B, Krajewska-Kułak E, Baranowska A, et al. The importance of the health education in life quality improvement in patients with psoriasis. Ann Acad Med Bialostocenn - sis 2005; 50 Supl. 1: 145-7.
22. Eghlileb AM, Davies EE, Finlay AY. Psoriasis has amajor secondary impact on the lives of family members and partners. Br J Dermatol 2007; 156: 1245-50.
23. Richards HL, Fortune DG, Griffiths CE, et al. The contribution of perceptions of stigmatization to disability in patients with psoriasis. J Psychosom Res 2001; 50: 11-5.
24. Jenner N, Campbell J, Plunkett A, et al. Cost of psoriasis: a study on the morbidity and financial effects of having psoriasis in Australia. Australas J Dermatol 2002; 43: 255-61.
25. Ginsburg IH. Psychological and psychophysiological aspects of psoriasis. Dermatol Clin 1995; 13: 793-804.
26. Zachariae R, Oster H, Bjerring P, et al. Effects of psychologic intervention on psoriasis: a preliminary report. J Am Acad Dermatol 1996, 34: 1008-15.
27. de Arruda LH, De Moraes AP. The impact of psoriasis on quality of life. Br J Dermatol 2001; Suppl. 58: 33-6.
28. Sharma N, Koranne RV, Singh RK. Psychiatric morbidity in psoriasis and vitiligo: a comparative study. J Dermatol 2001; 28: 419-23.
29. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 138: 846-50.
30. Burr S, Gradwell C. The psychosocial effects of skin diseases: need for support groups. Br J Nurs 1996; 19: 1177-82.
31. Rapp SR, Cottrell CA, Leary MR. Social coping strategies associated with quality of life decrements among psoriasis patients. Br J Dermatol 2001; 145: 610-6.
32. Weiss SC, Kimball AB, Liewehr DJ, et al. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 2002; 47: 512-8.
33. Devrimci-Ozguven H, Kundakci TN, Kumbasar H, et al. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000; 14: 267-71.